Gene-Disorder Association · Article
Gene
KLC1 Kinesin Light Chain 1
×
First reported
1950
Supporting publications
1
Approved treatment annotated
Association Review
In brief The association between KLC1 (Kinesin Light Chain 1) and Breast Cancer is supported by expert-curated evidence, supported by a single expert-curated source.
Sources
1
Clinical variants
2
Symptoms
4
Compounds
1
Trials
131 of 1,940 via KLC1 compounds
Publications
1
Contents
01
At a glance
Association overview A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.
Request access
02
Provenance
Evidence and sources 1 source
Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.
Request access
1 source summary
A gene summary alongside the source descriptions it was distilled from.
Request access
04
Breast Cancer
The disorder 23 database identifiers
The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).
Request access
05
Phenotype
Clinical features 1 clinical feature
The disorder’s clinical features (HPO) grouped by body system, each with observed frequency and penetrance.
Request access
06
ClinVar and variant evidence
Genetic basis 2 clinical variants
ClinVar variants reported for this pair, with disorder-specific significance, review status, molecular consequence and origin.
Request access
07
Interventions
Therapeutics 1 compound or drug
Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.
Request access
08
Human studies
Clinical trials 1,940 clinical trials
Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.
Request access
1 publication
Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.
Request access
10
Provenance
References & sources 7 references
Every source and publication cited across this dossier, as one numbered reference list.
Request access